M LUNG CA X ACEI

Lung Cancer Risk with ACE Inhibitors

Paul S. Mueller, MD, MPH, FACP reviewing Hicks BM et al. BMJ 2018 Oct 24

Risk was significantly higher with angiotensin-converting–enzyme inhibitors than with angiotensin-receptor blockers.